{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T19:57:11Z","timestamp":1773259031556,"version":"3.50.1"},"reference-count":44,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Directorate of Research, Innovation and Consultancy, University of Cape Coast","award":["DRIC-RSG-IN-24-005"],"award-info":[{"award-number":["DRIC-RSG-IN-24-005"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Natural gums have long served as essential excipients in pharmaceutical formulations, traditionally functioning as binders, disintegrants, suspending agents, and emulsifiers. Their role has expanded to include drug delivery carriers in advanced systems such as matrix formulations, gene therapy, and nanomedicine. Increasing attention has been given to natural gums over synthetic alternatives due to their non-toxicity, biodegradability, affordability, and availability. This study investigated the potential of\n                      <jats:italic>\n                        <jats:italic>Pentadesma butyracea<\/jats:italic>\n                      <\/jats:italic>\n                      gum as a matrix-forming agent for the extended release of diclofenac sodium.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      The crude gum was harvested from the stem bark of\n                      <jats:italic>\n                        <jats:italic>Pentadesma butyracea<\/jats:italic>\n                      <\/jats:italic>\n                      and purified using ethanol precipitation. Fourier-transform infrared spectroscopy (FTIR) was employed to assess potential interactions between the gum, diclofenac sodium, and other excipients. Matrix tablets (PM01\u2013PM05) containing varying concentrations (15\u201335%\n                      <jats:sup>w<\/jats:sup>\n                      \/\n                      <jats:sub>w<\/jats:sub>\n                      ) of the purified gum were prepared via wet granulation, along with a control batch (PM06) lacking the gum. Additionally, the PM01 formulation was optimised by incorporating xanthan gum at concentrations of 10\u201320%\n                      <jats:sup>w<\/jats:sup>\n                      \/\n                      <jats:sub>w<\/jats:sub>\n                      (PM01A\u2013PM01C). All formulations were assessed for weight and dimensional uniformity, mechanical integrity, drug content, and\n                      <jats:italic>\n                        <jats:italic>in vitro<\/jats:italic>\n                      <\/jats:italic>\n                      release characteristics. Comparative dissolution profiles were assessed against an innovator brand using the similarity (f\u2082) and difference (f\u2081) factors. Drug release kinetics and mechanisms were analysed using appropriate mathematical models.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      All batches passed the uniformity of weight and dimensions tests, drug content (99.11\u2013101.87%), friability (0.25\u20130.79%), hardness (7.74\u20138.83 Kgf), and tensile strength (1.29\u20131.49\u2009MPa). The control batch (PM06) failed to meet dissolution criteria, releasing only 60.46% of diclofenac sodium within 45 minutes. In contrast, formulations containing\n                      <jats:italic>\n                        <jats:italic>P. butyracea<\/jats:italic>\n                      <\/jats:italic>\n                      gum exhibited a gradual, concentration-dependent, time-mediated release, with all test batches (PM01\u2013PM05) releasing over 50% of the drug within 45 minutes. Among the optimised formulations, PM01C exhibited a modified release profile, with 19.90\u2009\u00b1\u20090.508% of the drug released at 2 hours and 100.26\u2009\u00b1\u20092.118% at 24 hours, consistent with the British Pharmacopoeia standards. The release profile of PM01C was comparable to the reference product (f\u2082\u2009=\u200979.35; f\u2081\u2009=\u20092.93) and followed zero-order kinetics. PM01A and PM01B exhibited Korsmeyer-Peppas release kinetics. Mechanistically, drug release occurred via non-Fickian diffusion for PM01C and Fickian diffusion for PM01A and PM01B.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      A matrix system comprising 15%\n                      <jats:sup>w<\/jats:sup>\n                      \/\n                      <jats:sub>w<\/jats:sub>\n                      <jats:italic>\n                        <jats:italic>P. butyracea<\/jats:italic>\n                      <\/jats:italic>\n                      gum and \u2265 20%\n                      <jats:sup>w<\/jats:sup>\n                      \/\n                      <jats:sub>w<\/jats:sub>\n                      xanthan gum effectively extended the release of diclofenac sodium over 24 hours, demonstrating its potential application in extended-release formulations.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0341668","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T18:35:11Z","timestamp":1769711711000},"page":"e0341668","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Investigation of the drug release modifying property of Pentadesma butyracea gum in diclofenac sodium matrix tablets"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0834-1518","authenticated-orcid":true,"given":"Mary-Ann","family":"Archer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwabena","family":"Ofori-Kwakye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4829-2447","authenticated-orcid":true,"given":"Raphael","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isaac Yaw","family":"Attah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederick William Akuffo","family":"Owusu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5598-7998","authenticated-orcid":true,"given":"Prince George","family":"Jnr Acquah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel Lugrie","family":"Kipo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2026,1,29]]},"reference":[{"issue":"1","key":"pone.0341668.ref001","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jconrel.2011.04.002","article-title":"Critical factors in the release of drugs from sustained release hydrophilic matrices","volume":"154","author":"C Maderuelo","year":"2011","journal-title":"J Control Release"},{"key":"pone.0341668.ref002","doi-asserted-by":"crossref","first-page":"618411","DOI":"10.3389\/fphar.2021.618411","article-title":"Advances in Oral Drug Delivery","volume":"12","author":"MS Alqahtani","year":"2021","journal-title":"Front Pharmacol"},{"issue":"6","key":"pone.0341668.ref003","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nrclinonc.2017.31","article-title":"The high price of anticancer drugs: origins, implications, barriers, solutions","volume":"14","author":"V Prasad","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"issue":"4","key":"pone.0341668.ref004","article-title":"An overview: Matrix tablets as sustained release","volume":"5","author":"D Nagendrakumar","year":"2014","journal-title":"Recent Research in Science and Technology"},{"issue":"4","key":"pone.0341668.ref005","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1021\/acs.chemrev.5b00346","article-title":"Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release","volume":"116","author":"N Kamaly","year":"2016","journal-title":"Chem Rev"},{"key":"pone.0341668.ref006","article-title":"British Pharmacopoeia","volume-title":"British Pharmacopoeia","year":"2021"},{"key":"pone.0341668.ref007","unstructured":"Indian Pharmacopoeia Commission. Indian Pharmacopoeia. Vols. I\u2013III. Government of India, Ministry of Health and Family Welfare.; 2018."},{"key":"pone.0341668.ref008","volume-title":"Aulton\u2019s Pharmaceutics E-Book: The Design and Manufacture of Medicines","author":"ME Aulton","year":"2017"},{"issue":"7","key":"pone.0341668.ref009","first-page":"369","article-title":"Investigation of blends of cashew and xanthan gums as a potential carrier for colonic delivery of ibuprofen","volume":"9","author":"MA Fosu","year":"2016","journal-title":"Int J Pharmtech Res"},{"key":"pone.0341668.ref010","volume-title":"Introduction to modern liquid chromatography","author":"LR Snyder","year":"2011"},{"key":"pone.0341668.ref011","unstructured":"P\u0113rkons I. The optimization of analytical parameters for screening and quantification of pharmaceutical residues in the environment [Internet] [PhD Thesis]. University of Latvia; 2021 [cited 2025 Nov 13]. Available from: https:\/\/dspace.lu.lv\/handle\/7\/54189"},{"key":"pone.0341668.ref012","volume-title":"HPLC for pharmaceutical scientists","author":"YV Kazakevich","year":"2006"},{"issue":"20","key":"pone.0341668.ref013","first-page":"05","article-title":"Validation of analytical procedures: text and methodology","volume":"1","year":"2005","journal-title":"Q2 (R1)"},{"issue":"1","key":"pone.0341668.ref014","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1208\/s12249-021-02203-7","article-title":"Simplified Model-Dependent and Model-Independent Approaches for Dissolution Profile Comparison for Oral Products: Regulatory Perspective for Generic Product Development","volume":"23","author":"S Kollipara","year":"2022","journal-title":"AAPS PharmSciTech"},{"issue":"6","key":"pone.0341668.ref015","first-page":"64","article-title":"Mathematical comparison of dissolution profiles","volume":"20","author":"JW Moore","year":"1996","journal-title":"Pharmaceutical technology"},{"issue":"4","key":"pone.0341668.ref016","doi-asserted-by":"crossref","first-page":"15","DOI":"10.14227\/DT040497P15","article-title":"fDA Guidance for Industry 1 Dissolution Testing of Immediate Release Solid Oral Dosage Forms","volume":"4","author":"VP Shah","year":"1997","journal-title":"Dissolution Technol"},{"issue":"1","key":"pone.0341668.ref017","first-page":"77","article-title":"In-vitro drug release characterization models","volume":"2","author":"G Singhvi","year":"2011","journal-title":"Int J Pharm Stud Res"},{"key":"pone.0341668.ref018","volume-title":"Quantitative calculations in pharmaceutical practice and research","author":"TP Hadjiioannou","year":"1993"},{"issue":"3","key":"pone.0341668.ref019","first-page":"217","article-title":"Kinetic modeling on drug release from controlled drug delivery systems","volume":"67","author":"S Dash","year":"2010","journal-title":"Acta Pol Pharm"},{"key":"pone.0341668.ref020","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/jps.2600521210","article-title":"Mechanism of sustained-action medication. theoretical analysis of rate of release of solid drugs dispersed in solid matrices","volume":"52","author":"T Higuchi","year":"1963","journal-title":"J Pharm Sci"},{"issue":"1","key":"pone.0341668.ref021","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0378-5173(83)90064-9","article-title":"Mechanisms of solute release from porous hydrophilic polymers","volume":"15","author":"RW Korsmeyer","year":"1983","journal-title":"Int J Pharm"},{"key":"pone.0341668.ref022","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jpba.2013.06.016","article-title":"Drug-excipient compatibility screening--role of thermoanalytical and spectroscopic techniques","volume":"87","author":"R Chadha","year":"2014","journal-title":"J Pharm Biomed Anal"},{"issue":"5","key":"pone.0341668.ref023","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1080\/05704928.2024.2438747","article-title":"Fourier transform infrared spectroscopy used in drug excipients compatibility studies","volume":"60","author":"AA Bunaciu","year":"2025","journal-title":"Appl Spectrosc Rev"},{"issue":"4","key":"pone.0341668.ref024","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.ijbiomac.2012.02.031","article-title":"X-ray diffraction, IR spectroscopy and thermal characterization of partially hydrolyzed guar gum","volume":"50","author":"D Mudgil","year":"2012","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"pone.0341668.ref025","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s10973-011-1782-4","article-title":"Preformulation studies on grewia gum as a formulation excipient","volume":"108","author":"EI Nep","year":"2012","journal-title":"J Therm Anal Calorim"},{"key":"pone.0341668.ref026","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.ijbiomac.2016.09.009","article-title":"Assessment of physical and structural characteristics of almond gum","volume":"93","author":"M Bashir","year":"2016","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"pone.0341668.ref027","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4103\/0250-474X.40327","article-title":"Design and optimization of diclofenac sodium controlled release solid dispersions by response surface methodology","volume":"70","author":"HN Shivakumar","year":"2008","journal-title":"Indian J Pharm Sci"},{"key":"pone.0341668.ref028","doi-asserted-by":"crossref","first-page":"30313","DOI":"10.1038\/srep30313","article-title":"Rapid detection of talcum powder in tea using FT-IR spectroscopy coupled with chemometrics","volume":"6","author":"X Li","year":"2016","journal-title":"Sci Rep"},{"issue":"12","key":"pone.0341668.ref029","doi-asserted-by":"crossref","first-page":"6544","DOI":"10.1007\/s10924-024-03401-7","article-title":"Extraction and characterization of microcrystalline cellulose (MCC) from durian rind for biocomposite application","volume":"32","author":"WS Yong","year":"2024","journal-title":"J Polym Environ"},{"key":"pone.0341668.ref030","author":"The United States Pharmacopeia","year":"2011","edition":"34"},{"key":"pone.0341668.ref031","doi-asserted-by":"crossref","first-page":"124336","DOI":"10.1016\/j.ijpharm.2024.124336","article-title":"Prediction of in-vitro dissolution and tablet hardness from optical porosity measurements","volume":"660","author":"S Sacher","year":"2024","journal-title":"Int J Pharm"},{"issue":"4","key":"pone.0341668.ref032","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2025.e42902","article-title":"Characteristics of microcrystalline cellulose derived from oil palm trunk slabs and its potential for use as tablet diluent","volume":"11","author":"C Jantarat","year":"2025","journal-title":"Heliyon"},{"issue":"4","key":"pone.0341668.ref033","first-page":"52","article-title":"Evolutions in direct compression","volume":"29","author":"D McCormick","year":"2005","journal-title":"Pharmaceutical technology"},{"issue":"04","key":"pone.0341668.ref034","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.31788\/RJC.2021.1446373","article-title":"Development and validation of a new HPLC bioanalytical internal standard method for the analysis of remdesivirin human plasma","volume":"14","author":"D Kishore","year":"2022","journal-title":"RJC"},{"issue":"1","key":"pone.0341668.ref035","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jsps.2018.07.020","article-title":"Development and validation of a new HPLC analytical method for the determination of diclofenac in tablets","volume":"27","author":"BT Alquadeib","year":"2019","journal-title":"Saudi Pharm J"},{"issue":"4","key":"pone.0341668.ref036","doi-asserted-by":"crossref","first-page":"22","DOI":"10.14227\/DT120405P22","article-title":"Assessment of similarity factor using different weighting approaches","volume":"12","author":"MC Gohel","year":"2005","journal-title":"Dissolut Technol"},{"issue":"4","key":"pone.0341668.ref037","first-page":"1597","article-title":"Natural polymers\u2013A comprehensive review","volume":"3","author":"VS Kulkarni","year":"2012","journal-title":"Int J Res Pharm Biomed Sci"},{"key":"pone.0341668.ref038","first-page":"5340953","article-title":"Development and In Vitro Evaluation of Oral Capsules from Antiaris: A Convenient Substitute for Peripheral Neuropathy","volume":"2022","author":"M-A Archer","year":"2022","journal-title":"Adv Pharmacol Pharm Sci"},{"key":"pone.0341668.ref039","unstructured":"Akhtar H, Razvi N, Khan S, Khan K, Ullah S, Ansari RA. Application of Quality Control Parameters and Model Dependent and Independent Approaches on Different Brands of Itopride HCL 250mg Available in Karachi, Pakistan. Annals of Jinnah Sindh Medical University. 2025;11(1):9\u201314."},{"issue":"6","key":"pone.0341668.ref040","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1002\/cben.202300027","article-title":"Kinetic Modeling to Explain the Release of Medicine from Drug Delivery Systems","volume":"10","author":"M Askarizadeh","year":"2023","journal-title":"ChemBioEng Reviews"},{"key":"pone.0341668.ref041","first-page":"613","volume-title":"Korsmeyer-peppas, peppas-sahlin, and brazel-peppas: models of drug release. In: The ADME encyclopedia: A comprehensive guide on biopharmacy and pharmacokinetics","author":"A Talevi","year":"2022"},{"key":"pone.0341668.ref042","doi-asserted-by":"crossref","first-page":"102788","DOI":"10.1016\/j.jddst.2021.102788","article-title":"Effervescent floating matrix tablets of a novel anti-cancer drug neratinib for breast cancer treatment","volume":"66","author":"M Rahamathulla","year":"2021","journal-title":"Journal of Drug Delivery Science and Technology"},{"key":"pone.0341668.ref043","first-page":"613","volume-title":"Korsmeyer-peppas, peppas-sahlin, and brazel-peppas: models of drug release. In: The ADME encyclopedia: A comprehensive guide on biopharmacy and pharmacokinetics","author":"A Talevi","year":"2022"},{"key":"pone.0341668.ref044","first-page":"6672277","article-title":"Pectin from Okra (Abelmoschus esculentus L.) Has Potential as a Drug Release Modifier in Matrix Tablets","volume":"2021","author":"ME Boakye-Gyasi","year":"2021","journal-title":"ScientificWorldJournal"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0341668","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T18:35:22Z","timestamp":1769711722000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0341668"}},"subtitle":[],"editor":[{"given":"Claudio J.","family":"Salomon","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2026,1,29]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0341668","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,29]]}}}